1. Home
  2. VABK vs ACRS Comparison

VABK vs ACRS Comparison

Compare VABK & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$40.47

Market Cap

203.8M

Sector

Finance

ML Signal

HOLD

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$2.81

Market Cap

230.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
ACRS
Founded
1998
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.8M
230.8M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
VABK
ACRS
Price
$40.47
$2.81
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.75
AVG Volume (30 Days)
9.1K
1.4M
Earning Date
10-23-2025
11-06-2025
Dividend Yield
3.56%
N/A
EPS Growth
14.22
N/A
EPS
3.30
N/A
Revenue
$56,512,000.00
$15,742,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.28
N/A
Revenue Growth
10.39
N/A
52 Week Low
$33.66
$1.05
52 Week High
$44.57
$4.24

Technical Indicators

Market Signals
Indicator
VABK
ACRS
Relative Strength Index (RSI) 60.53 64.58
Support Level $38.11 $2.34
Resistance Level $39.38 $2.57
Average True Range (ATR) 0.90 0.21
MACD 0.13 0.04
Stochastic Oscillator 100.00 87.31

Price Performance

Historical Comparison
VABK
ACRS

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: